المؤلفون: C. van Marcke (10836498), N. Honoré (10836501), A. van der Elst (10836504), S. Beyaert (10836507), F. Derouane (10836510), C. Dumont (10836513), F. Aboubakar Nana (10836516), J. F. Baurain (10836519), I. Borbath (10836522), P. Collard (10836525), F. Cornélis (10836528), A. De Cuyper (10836531), F. P. Duhoux (10836534), B. Filleul (10836537), R. Galot (10836540), M. Gizzi (10836543), F. Mazzeo (10836546), T. Pieters (10836549), E. Seront (10836552), I. Sinapi (10836555), M. Van den Eynde (10836558), N. Whenham (10836561), J. C. Yombi (10836564), A. Scohy (10836567), A. van Maanen (10836570), J. P. Machiels (10836573)

مصطلحات موضوعية: Medicine, Pharmacology, Biotechnology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Computational Biology, Systemic anti-cancer treatment, Non-severe COVID-19, Ambulatory, Safety

Relation: https://figshare.com/articles/journal_contribution/Additional_file_1_of_Safety_of_systemic_anti-cancer_treatment_in_oncology_patients_with_non-severe_COVID-19_a_cohort_study/14634033

الاتاحة: https://doi.org/10.6084/m9.figshare.14634033.v1